Search
for
Sort by
Research 31–60 of 1000+
- Hair Cycle Control by Estrogens: Catagen Induction via Estrogen Receptor (ER)-α Is Checked by ERβ Signaling
- Allergic contact dermatitis to topical brimonidine
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Androgen Receptor Ligands: Agonists and Antagonists
- Topical absorption and systemic toxicity
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?
- Role of skin enzymes in metabolism of topical drugs
- Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Topical use of systemic drugs in dermatology: A comprehensive review
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
- The Effect of Topical Minoxidil Pretreatment on Nonsurgical Delay of Rat Cutaneous Flaps: Further Studies
- Preparation and Physicochemical Evaluation of Topical Cream Ivermectin 1% for Treatment of Rosacea
- Use of Topical Minoxidil in Latissimus Dorsi Flap– Our Experience
- Comparative study of efficacy of excimer light therapy vs intralesional triamcinolone vs topical 5% minoxidil: an observational study
- Comparative study of efficacy of excimer light therapy vs. intralesional triamcinolone vs. topical 5% minoxidil for alopecia areata: an observational study
- Mechanism of PPARα agonist in alopecia areata
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Bakteriyel Selüloz Tabanlı Hidrojel Taşıyıcı ile Topikal Uygulanan Tideglusib’in Sıçanlarda Oluşturulan Palatinal Yaranın İyileşmesi Üzerine Etkisinin Makroskobik Değerlendirmesi: Bir Öncül Çalışma
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia
- Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Treatment of Alopecia Areata in Mice by Stimulating the Hair Follicles Using Parathyroid Hormone Agonists Linked to a Collagen Binding Domain